Earnings summaries and quarterly performance for CME GROUP.
Executive leadership at CME GROUP.
Terrence A. Duffy
Chairman and Chief Executive Officer
Derek Sammann
Senior Managing Director, Global Head of Commodities Markets
Hilda Harris Piell
Chief Human Resources Officer
Jack Tobin
Managing Director and Chief Accounting Officer
Jonathan Marcus
Senior Managing Director and General Counsel
Julie Winkler
Chief Commercial Officer
Kendal Vroman
Chief Transformation Officer
Lynne Fitzpatrick
President and Chief Financial Officer
Michael Dennis
Senior Managing Director, Global Head of Fixed Income
Sunil Cutinho
Chief Information Officer
Suzanne Sprague
Chief Operating Officer and Global Head of Clearing
Tim McCourt
Senior Managing Director, Global Head of Equities, FX and Alternate Products
Board of directors at CME GROUP.
Bryan T. Durkin
Director
Charles P. Carey
Director
Daniel G. Kaye
Director
Deborah J. Lucas
Director
Dennis A. Suskind
Lead Independent Director
Elizabeth A. Cook
Director
Harold Ford Jr.
Director
Howard J. Siegel
Director
Kathryn Benesh
Director
Martin J. Gepsman
Director
Patrick J. Mulchrone
Director
Patrick W. Maloney
Director
Phyllis M. Lockett
Director
Rahael Seifu
Director
Robert J. Tierney Jr.
Director
Timothy S. Bitsberger
Director
William R. Shepard
Director
William W. Hobert
Director
Research analysts who have asked questions during CME GROUP earnings calls.
Brian Bedell
Deutsche Bank
9 questions for CME
Michael Cyprys
Morgan Stanley
9 questions for CME
Craig Siegenthaler
Bank of America
8 questions for CME
Patrick Moley
Piper Sandler & Co.
8 questions for CME
Dan Fannon
Jefferies & Company Inc.
6 questions for CME
Kenneth Worthington
JPMorgan Chase & Co.
6 questions for CME
Kyle Voigt
Keefe, Bruyette & Woods
6 questions for CME
Alex Kramm
UBS Group AG
5 questions for CME
Benjamin Budish
Barclays PLC
5 questions for CME
Christopher Allen
Citigroup
5 questions for CME
Simon Clinch
Redburn Atlantic
5 questions for CME
Ben Budish
Barclays PLC
4 questions for CME
William Katz
TD Cowen
4 questions for CME
Alexander Blostein
Goldman Sachs
3 questions for CME
Ashish Sabadra
RBC Capital Markets
3 questions for CME
Daniel Fannon
Jefferies Financial Group Inc.
3 questions for CME
Kwun Sum Lau
Oppenheimer
3 questions for CME
Anthony Valentini
Goldman Sachs
2 questions for CME
Bill Katz
TD Securities
2 questions for CME
Chris Allen
Citi
2 questions for CME
Eli Abboud
Bank of America
2 questions for CME
Ken Worthington
JPMorgan
2 questions for CME
Owen Lau
Oppenheimer & Co. Inc.
2 questions for CME
Will Chi
RBC Capital Markets
2 questions for CME
William Qi
RBC Capital Markets
2 questions for CME
Kyle Voit
KBW
1 question for CME
Simon Alistair Clinch
Redburn Atlantic
1 question for CME
Recent press releases and 8-K filings for CME.
- CME reported 28.1 million average daily volume in 2025 (+6% YoY) and 6% revenue growth, achieving a 69.4% adjusted operating margin; YTD ADV reached 35.5 million (+16%) as of early 2026
- Non-US participation is a key growth driver, with non-US volumes growing ~10% CAGR over five years and 47% of FX and metals ADV originating outside the U.S. in Q4 2025
- Retail expansion via micro contracts—e.g., 1-ounce gold at 35% of the standard contract price—has onboarded new-to-futures traders, generating high-margin volume (45% of retail ADV is non-U.S.)
- Commodities remain core, with $1.8 B in energy, $650 M in agriculture and $350 M in metals revenues, and $80 B/day of cross-margin offsets enhancing customer capital efficiency
- Non-transactional revenues include an $800 M market data business (+13% YoY), SPDJI royalties and $600 M in interest on collateral; CME offers a 4.1% dividend yield (incl. $6.15 annual variable dividend) and has an active share buyback program
- CME Group positions itself as the world’s leading derivatives exchange with a dual mandate of price transparency through benchmark futures and options across six major asset classes and risk management via its vertically integrated clearinghouse.
- In CY 2025, CME achieved 6% ADV growth to 28.1 million contracts/day and 6% revenue growth with a 69.4% adjusted operating margin; year-to-date ADV is 35.5 million, up 16%.
- Non-U.S. volumes are a key growth driver, led by Europe, with non-U.S. business growing at ~10% over five years and higher rate-per-contract margins.
- Retail expansion via the micro contract suite (e.g., Micro Gold, Micro E-mini) is attracting net new customers, with 45% of retail volume now from non-U.S. clients.
- Diversified non-transactional revenues include an $800 m market data business (+13%), income from a 27% S&P Dow Jones Indices stake, and $600 m in interest on collateral, supporting a 4.1% dividend yield, annual variable dividend, and ongoing share buyback.
- CME Group reported 2025 ADV of 28.1 M contracts (+6% YoY) and revenues +6%, with $5.3 B transactional and $1.7 B non-transactional revenue, achieving 69.4% adjusted operating margin; YTD ADV reached 35.5 M (+16%), peaking at 45 M contracts during recent volatility.
- Growth is driven by the non-U.S. client base, with nearly 50% of FX and metals volumes from outside the U.S. and non-U.S. ADV outpacing U.S. at ~10% CAGR over five years, yielding higher rate-per-contract margins.
- CME is expanding its retail footprint via micro-contracts (e.g., 1-ounce gold), capturing new-to-futures traders; this high-margin segment now constitutes ~45% of retail volume outside the U.S..
- The commodities segment delivers ~$1.8 B in energy, $650 M in agriculture, and $350 M in metals, and leverages $80 B/day in cross-margin offsets to enhance capital efficiency and client stickiness.
- CME Group achieved a record 37.6 million average daily volume (ADV) in February, 14% higher year-over-year.
- Interest Rate ADV hit 21.3 million contracts, including a record 13.7 million U.S. Treasury futures and options ADV.
- Equity Index ADV reached 8.4 million, Energy ADV was 3.2 million, and Agricultural ADV was 2.3 million contracts in February.
- International ADV set a record 11.6 million contracts, with EMEA at 8.7 million and APAC ADV up 16% to 2.4 million.
- CME Group’s U.S. Treasury futures and options open interest (OI) hit a record 36,328,151 contracts on February 19, 2026, surpassing the prior high of 35,120,066 set in November 2025
- Key product records include 5.8 million 2-Year note contracts, 7.9 million 5-Year note contracts, 12.6 million 10-Year note contracts, and 3.6 million 30-Year bond contracts
- A record 2,100 large open interest holders were reported in the CFTC’s February 10 Commitment of Traders report
- CME Group noted over $25 billion in daily margin savings and portfolio/cross-margining benefits for its U.S. Treasury and SOFR futures
- CME Group will offer 24/7 continuous trading for Bitcoin- and Ethereum-linked futures and options on CME Globex starting May 29, pending regulatory approval, with a two-hour weekly maintenance window.
- The move responds to record client demand—about $3 trillion in notional crypto volume in 2025 and a 46% Y/Y rise in average daily crypto volume to ~407,200 contracts, with open interest near 335,400.
- Weekend trades will carry the next business day’s trade date, while clearing, settlement and regulatory reporting will follow traditional post-trade processes.
- Aimed at closing timing gaps for institutional hedging between regulated derivatives and spot markets, the plan has CFTC chair Mike Selig’s support but still requires regulatory sign-off.
- CME Group will offer 24/7 trading of regulated cryptocurrency futures and options starting May 29, pending regulatory approval.
- In 2025, its cryptocurrency futures and options reached a record $3 trillion in notional volume, reflecting robust client demand.
- Year-to-date 2026 highlights include average daily volume of 407,200 contracts (+46% YoY), average daily open interest of 335,400 contracts (+7% YoY) and futures ADV of 403,900 contracts (+47% YoY).
- CME Group declares an annual variable dividend of $6.15 per share, totaling approximately $2.2 billion, based on 2025 results, payable March 26, 2026, to shareholders of record March 10, 2026.
- The Q1 2026 regular dividend is set at $1.30 per share, a $0.05 increase from the prior level.
- Combined with quarterly dividends paid during 2025, total annual payouts reach $4.0 billion, representing a 4.2% total dividend yield based on the average 2025 closing stock price.
- CME Group plans to introduce four cash-settled South Asia edible oil futures contracts on March 2, 2026, pending regulatory approval, covering soybean oil, crude palm oil and two spread products.
- The contracts use Fastmarkets Soyoil CFR India and Crude Palm Oil CFR West Coast India indices to enhance price discovery and risk management in South Asia, which accounts for approximately 45% of soyoil and 30% of palm oil trade globally.
- In 2025, CME Group achieved record agricultural average daily volume of 1.9 million contracts, including 293,000 soybean futures and 182,000 soybean oil futures contracts.
- The new products will be listed on CBOT under its rules, offering additional hedging tools for edible oil price exposure.
- CME Group launched Cardano (ADA), Chainlink (LINK) and Stellar (XLM) futures on February 9, 2026, expanding its regulated cryptocurrency product suite.
- The first LINK and XLM futures trades were executed between FalconX and Marex, while the inaugural ADA futures trade occurred between Cumberland DRW and Wintermute.
- These contracts are available in micro- and larger-sized formats, offering capital-efficient tools for institutional price risk management.
- CME Group stated the launch reflects growing client demand for trusted, regulated crypto derivatives.
Fintool News
In-depth analysis and coverage of CME GROUP.

CME Group Goes 24/7: World's Largest Derivatives Exchange Brings Always-On Trading to Crypto Futures

CME Crypto Derivatives Hit Record $12 Billion Daily Volume as Institutional Adoption Accelerates

The Prediction Markets War Heats Up: FanDuel, DraftKings, and Coinbase Race for $100B Market
Quarterly earnings call transcripts for CME GROUP.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
